In an overview of GLP-1’s biological functions in sepsis and its emerging therapeutic potential, 27 studies were analyzed, focusing on the organ-protective effects of GLP-1, GLP-1RAs, and DPP-4 inhibitors in in vivo models of sepsis. The gene discussed is DPP4; the disease is Sepsis.